Forex Today: Commodities rise on “reflation trade” dollar edges lower, stimulus news eyed

Here is what you need to know on Monday, February 22:

Markets are on the back foot amid concerns of a quick return to growth, reflating or even inflating prices, with bond yields, oil and copper on the rise, but the dollar falling. The UK's roadmap of returning to normal, the German IFO Business Climate and news related to US fiscal stimulus are eyed. 

Reflation trade: Investors are awaiting what President Joe Biden and fellow Democrats pass in Congress – up to $1.9 trillion in covid relief – and what they might do afterward. The administration is considering vast infrastructure spending. Prospects of high debt issuance have caused a sell-off in bonds, but the higher yields have yet to boost the dollar. 

Commodities "supercycle:" China's 2020 growth and prospects of a US rebound have boosted oil prices after a short profit-taking move. It is unclear how Saudi Arabia and Russia will manage output cuts moving forward. Copper has surged past $9,000 amid supply issues on top of expectations for robust global growth.

Bitcoin hit a new high above $58,000, surpassing a valuation of $1 trillion at one point. Ethereum is trading near its record of over $2,000. Tesla's founder Elon Musk touted Dogecoin once again. 

Jerome Powell, Chairman of the Federal Reserve, is scheduled to testify before Congress on Tuesday and on Wednesday, yet his prepared remarks may come out as early as Monday. The central banker's comments on inflation, employment and other topics will be closely watched. 

UK: GBP/USD is holding onto 1.40 it reached late last week and ahead of a highly anticipated speech by Prime Minister Boris Johnson on easing restrictions. According to reports, he is set to lay out a cautious roadmap to reopening and stress the importance of vaccinations. 

Europe: The German IFO Business Climate figures for February are set to show an improvement in sentiment, echoing similar figures from ZEW. EUR/USD has been hovering above 1.21. 

Vaccines: Another study in Israel has shown that the Pfizer/BioNTech jabs have dramatically reduced infection and not only disease. The country of nine million has already reached 47% of its population with at least one shot. The US FDA is scheduled to discuss Johnson and Johnson's single-shot vaccine on Friday. 

More Five factors moving the US dollar in 2021 and not necessarily to the downside.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Feed news Join Telegram

Recommended content

Recommended content

Editors’ Picks

EUR/USD recovers modestly, trades below 1.0550

EUR/USD recovers modestly, trades below 1.0550

EUR/USD has managed to stage a rebound after having declined toward 1.0500 in the early American session. The negative shift witnessed in market sentiment after the latest US data, however, helps the dollar find demand and doesn't allow the pair to extend its recovery.


GBP/USD trades below 1.2200 pressured by risk aversion

GBP/USD trades below 1.2200 pressured by risk aversion

GBP/USD has extended its daily slide and touched a fresh five-day low below 1.220 in the second half of the day on Tuesday. Wall Street's main indexes are suffering heavy losses, providing a boost to the safe-haven dollar in the American session.


Gold continues to fluctuate in tight range above $1,820

Gold continues to fluctuate in tight range above $1,820

Gold edged lower in the early American session but managed to erase its daily losses. With the 10-year US T-bond yield falling into negative territory amid risk aversion on Tuesday, XAU/USD holds its ground and continues to trade near $1,820.

Gold News

Former Ripple CTO is dumping millions of XRP, traders beware

Former Ripple CTO is dumping millions of XRP, traders beware

XRP price shows promise that it is ready to trigger a massive run-up as the first half of the year comes to an end. There are three reasons why investors should be bullish on Ripple.

Read more

FXStreet Premium users exceed expectations

FXStreet Premium users exceed expectations

Tap into our 20 years Forex trading experience and get ahead of the markets. Maximize our actionable content, be part of our community, and chat with our experts. Join FXStreet Premium today!